These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4884773)

  • 41. Comparison between high daily dosage of isoniazid in divided doses and low daily dosage in a single dose in triple-drug regimens.
    Tubercle; 1968 Jun; 49(2):170-9. PubMed ID: 5664315
    [No Abstract]   [Full Text] [Related]  

  • 42. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
    Ganguin HG; Cramer G; Götz J; Holzhauer H; Niegsch G; Sieler H; Velten G; Völker L
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):107-15. PubMed ID: 4203235
    [No Abstract]   [Full Text] [Related]  

  • 43. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
    [No Abstract]   [Full Text] [Related]  

  • 44. Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1972 May; 1(7760):1079-85. PubMed ID: 4112569
    [No Abstract]   [Full Text] [Related]  

  • 45. Response to treatment with isoniazid plus PAS of tuberculous patients with primary isoniazid resistance.
    Tripathy SP; Menon NK; Mitchison DA; Narayana AS; Somasundaram PA; Stott H; Velu S
    Tubercle; 1969 Sep; 50(3):257-68. PubMed ID: 4981496
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical applications of ethambutol.
    Pyle MM
    Tubercle; 1969 Mar; 50():Suppl:30-2. PubMed ID: 4918611
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
    [No Abstract]   [Full Text] [Related]  

  • 48. Streptomycin plus PAS plus pyrazinamide in the retreatment of pulmonary tuberxulisis in East Africa.
    Tubercle; 1971 Sep; 52(3):191-8. PubMed ID: 4938216
    [No Abstract]   [Full Text] [Related]  

  • 49. [Polychemotherapy of patients with chronic destructive forms of pulmonary tuberculosis in interregional tuberculosis hospitals].
    Shimko NP; Maĭovetskaia NS; Severina MV; Alimova LV
    Probl Tuberk; 1989; (3):60-4. PubMed ID: 2726714
    [No Abstract]   [Full Text] [Related]  

  • 50. A comparison of two regimens of streptomycin plus PAS in the retreatment of pulmonary tuberculosis.
    Tubercle; 1968 Mar; 49(1):70-8. PubMed ID: 5660586
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect and treatment problems of secondary antitubercular agents].
    Dissmann E
    Wien Med Wochenschr; 1966 Nov; 116(47):996-8. PubMed ID: 6011782
    [No Abstract]   [Full Text] [Related]  

  • 52. A study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis.
    Fox W; Robinson DK; Tall R; Kent PW; Macfadyen DM
    Tubercle; 1969 Jun; 50(2):125-43. PubMed ID: 4894707
    [No Abstract]   [Full Text] [Related]  

  • 53. Rifampin-isoniazid compared with PAS-isoniazid-streptomycin in initial treatment of pulmonary tuberculosis. A controlled cooperative trial.
    Boman G
    Chest; 1972 Jun; 61(6):533-8. PubMed ID: 5032151
    [No Abstract]   [Full Text] [Related]  

  • 54. Intermittent chemotherapy or improvement of initial treatment in tuberculosis.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):1-6. PubMed ID: 4949334
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of severe open cavitary pulmonary tuberculosis with a combination of rifampicin and isoprodian (author's transl)].
    Pereira V
    Prax Pneumol; 1976 Sep; 30(9):584-7. PubMed ID: 967829
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of the combination therapy of capreomycin. Ethionamide. Cycloserine with that of kanamycin. Ethionamide. Cycloserin in the retreatment of pulmonary tuberculosis.
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):1-13. PubMed ID: 4990959
    [No Abstract]   [Full Text] [Related]  

  • 57. The management of drug-resistant pulmonary tuberculosis.
    Pines A
    Br J Dis Chest; 1968 Jan; 62(1):1-10. PubMed ID: 4872326
    [No Abstract]   [Full Text] [Related]  

  • 58. Implications of the Hong Kong Study of policies of sensitivity testing.
    Mitchison DA
    Bull Int Union Tuberc; 1972 Feb; 47():9-14. PubMed ID: 5077110
    [No Abstract]   [Full Text] [Related]  

  • 59. [Intravenous method of chemotherapy of pulmonary tuberculosis].
    Rudoĭ NM; Utkin VV
    Probl Tuberk; 1969; 47(3):23-7. PubMed ID: 5354630
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
    Bernard E
    Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.